Main Menu

Our Work

Search Term:

  • Life Sciences
Clear All

Showing 13 - 24 of 59 results

  • Retained to provide expert testimony on behalf of a specialty pharmacy in a matter involving allegations of Anti-Kickback Statute violations. 

  • Computed damages arising from lost sales of a major antiviral pharmaceutical product. The dispute alleged breach of contract, specifically through the failure to provide adequate marketing and promotional support. Developed but-for ...

  • Provided consulting expertise on issues of liability, causation, and damages on behalf of a pharmaceutical manufacturer alleged to have engaged in off-label marketing.

  • In response to changes to the regulatory requirements for reporting prices to Texas Medicaid’s Vendor Drug Program, collaborated with in-house and outside legal counsel to support a generic manufacturer in developing functional price ...

  • Prepared a report for a trade group representing research-based pharmaceutical and biotechnology companies that evaluated potential compliance costs resulting from new Affordable Care Act requirements related to the calculation of AMP.

  • In United States of America, et al., ex rel. Ronald J. Streck v. Allegan, Inc., et al., estimated the potential exposure of a pharmaceutical manufacturer facing allegations that it failed to factor off-invoice price increases into its AMP ...

  • Served as lead consulting expert for a major drug manufacturer throughout a multiyear government investigation spanning several products and allegations, including that certain alleged price concessions were not factored into the ...

  • Prepared a white paper for the National Association of Manufacturers (NAM) to evaluate restrictive trade policies in place in India, among which is failure to grant patents on innovative medicines. The report accompanies NAM’s submission ...

  • On behalf of Medicaid disability claimants, evaluated a state Medicaid agency’s application of an econometric model for benefit determination and provided guidance on best arguments against such application.

  • Performed an economic impact analysis of research and development (R&D) activities for a leading non-profit stem cell foundation, working with scientists to evaluate programs and assess impact on future economic activity.

  • For a leading industry organization and a global life sciences company, analyzed R&D activity by life sciences companies, strategic issues and trends relating to emerging funding models for R&D including venture philanthropy and ...

  • Served as lead consulting expert for a major drug manufacturer throughout a multiyear government investigation spanning several products and qui tam allegations. Provided consulting expertise on liability, causation, and damages ...

Jump to Page